HBT Financial, Inc. to Announce First Quarter 2024 Financial Results on April 22, 2024
BLOOMINGTON, Ill., April 11, 2024 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding […]
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]
NMI Holdings, Inc. to Announce First Quarter 2024 Financial Results on April 30, 2024
EMERYVILLE, Calif., April 11, 2024 (GLOBE NEWSWIRE) — NMI Holdings, Inc., (NASDAQ: NMIH), the parent company of National Mortgage Insurance […]
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024, […]
NFT LTD. ANNOUNCES 1 FOR 50 REVERSE SHARE SPLIT
Hong Kong, April 11, 2024 (GLOBE NEWSWIRE) — NFT Ltd. (NYSE American: MI) (“Company” or “NFT”, formerly known as Takung […]
Ultralife Corporation to Report First Quarter Results on April 25, 2024
NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the […]
TSX News -
Gibson Energy Confirms 2024 First Quarter Earnings Release and Annual General Meeting Dates and Provides Conference Call & Webcast Details
CALGARY, Alberta, April 11, 2024 (GLOBE NEWSWIRE) — Gibson Energy Inc. (“Gibson” or the “Company”) announced today that it expects […]
Medallion Bank Announces Fintech Strategic Partnership With TriBeam Financial
SALT LAKE CITY, April 11, 2024 (GLOBE NEWSWIRE) — Medallion Bank (Nasdaq: MBNKP, the “Bank”), an FDIC-insured bank providing consumer […]
Sotera Health Announces First-Quarter 2024 Earnings Release Date
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization […]
Nurix Therapeutics Announces Proposed Public Offering
SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]
